The Traderszone Network

Published in TZ Latest News 12 January, 2015 by The TZ Newswire Staff

$1.8B drug deal to target cancer at genetic level

Foundation Medicine CEO Michael Pellini tells CNBC, “It’s an important day for patients battling cancer.”